JAGLX Holdings Information

JAGLX is a mutual fund with a total of 104 individual holdings. The top holdings are Eli Lilly and Company stock at 9.66%, Johnson & Johnson at 5.59%, AstraZeneca at 4.27%, UnitedHealth Group at 3.44%, and AbbVie at 3.39%.

Total Holdings

104

Top 10 Percentage

38.87%

Asset Class

Equity

Fund Category

Health

Assets

5.40B

Forward PE Ratio

19.57

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	9.66%	481,268
2	JNJ	Johnson & Johnson	5.59%	1,444,532
3	LON: AZN	AstraZeneca PLC	4.27%	1,240,485
4	UNH	UnitedHealth Group Incorporated	3.44%	557,669
5	ABBV	AbbVie Inc.	3.39%	794,492
6	ABT	Abbott Laboratories	2.65%	1,130,599
7	ARGX	argenx SE	2.63%	167,389
8	NVSN.MX	Novartis AG ADR	2.50%	971,981
9	PRAX	Praxis Precision Medicines, Inc.	2.39%	433,759
10	BSX	Boston Scientific Corporation	2.35%	1,318,073
11	ISRG	Intuitive Surgical, Inc.	2.31%	217,842
12	TMO	Thermo Fisher Scientific Inc.	2.30%	212,153
13	EPA: SAN	Sanofi	2.29%	1,261,100
14	AMGN	Amgen Inc.	2.15%	351,048
15	SWX: ROG	Roche Holding AG	2.13%	275,465
16	BBIO	BridgeBio Pharma, Inc.	2.11%	1,477,488
17	VRTX	Vertex Pharmaceuticals Incorporated	2.04%	240,492
18	HCA	HCA Healthcare, Inc.	1.96%	224,626
19	RVMD	Revolution Medicines, Inc.	1.93%	1,294,495
20	DHR	Danaher Corporation	1.78%	415,394
21	SYK	Stryker Corporation	1.64%	249,313
22	CVS	CVS Health Corporation	1.51%	1,021,515
23	ASND	Ascendis Pharma A/S	1.50%	375,734
24	MDGL	Madrigal Pharmaceuticals, Inc.	1.43%	131,174
25	MCK	McKesson Corporation	1.28%	83,343

Showing 25 of 104 holdings

Subscribe to see the full list

Activate Now

As of Dec 31, 2025